Literature DB >> 22929565

Pulse pressure and mild cognitive impairment.

Teodora Yaneva-Sirakova1, Rumiana Tarnovska-Kadreva, Latchezar Traykov.   

Abstract

OBJECTIVE: Patients with suboptimal blood pressure (BP) control may remain with an elevated cardiovascular risk and risk for cognitive impairment. Pulse pressure (PP) assessed with ambulatory BP monitoring (ABPM) or self-measurement so far has been an underestimated risk factor for target organ damage.
METHODS: One hundred and forty-eight patients were screened: 51 men (34.5%) and 97 women (65.5%), mean age 64.16 ± 11.18 years and a mean hypertension history of 13.1 ± 11.05 years. We gathered full medical and hypertension history, physical examination, laboratory screening and ambulatory blood pressure monitoring. Neuropsychological profile was assessed with tests (NPTs): Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).
RESULTS: Regression analysis found a correlation between day and night PP and NPT results. Mann-Whitney Test (α less than 0.05) was used to find a significant difference (P = 0.02 for MMSE) in the mean values of the NPT results between the groups with PP more than 50 and PP 50  mmHg or less. The result was not age dependent. There was also a significant difference between mean values of day-PP (P = 0.01) and night-PP (P = 0.02) between patients with cognitive impairment and those without (respectively more than 55  mmHg and less than 55  mmHg).
CONCLUSION: Elevated PP during the day, the night or with self-measurement is correlated with cognitive impairment. It is a marker of large artery stiffness and target organ damage not only in the very elderly, but also in younger individuals (mean age 64.16 years).

Entities:  

Mesh:

Year:  2012        PMID: 22929565     DOI: 10.2459/JCM.0b013e328357ba78

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  8 in total

1.  High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals.

Authors:  Iolanda Riba-Llena; Cristina Nafría; Josefina Filomena; José L Tovar; Ernest Vinyoles; Xavier Mundet; Carmen I Jarca; Andrea Vilar-Bergua; Joan Montaner; Pilar Delgado
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Mortality rate of high cardiovascular risk patients with mild cognitive impairment.

Authors:  Teodora Yaneva-Sirakova; Latchezar Traykov
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.

Authors:  G Peggy McFall; Shraddha Sapkota; Kirstie L McDermott; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2016-03-10       Impact factor: 4.673

4.  Pulse pressure findings following upper cervical care: a practice-based observational study.

Authors:  Robert Kessinger; Trevor Qualls; John Hart; Henri Dallies; Michael Anderson; Jered Wayland; Leldon Bradshaw
Journal:  J Can Chiropr Assoc       Date:  2019-04

5.  "Do it-yourself": Home blood pressure as a predictor of traditional and everyday cognition in older adults.

Authors:  Sophie E Yeung; Wendy Loken Thornton
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

6.  Comparison of Central, Ambulatory, Home and Office Blood Pressure Measurement as Risk Markers for Mild Cognitive Impairment in Hypertensive Patients.

Authors:  Teodora Yaneva-Sirakova; Latchezar Traykov; Julia Petrova; Dobrin Vassilev
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-08-29

7.  Vascular Mild Cognitive Impairment: Identifying Disease in Community-Dwelling Older Adults, Reducing Risk Factors, and Providing Support. The Osaki-Tajiri and Kurihara Projects.

Authors:  Kenichi Meguro; Hiroko H Dodge
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Alzheimer's Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers.

Authors:  Shraddha Sapkota; Tao Huan; Tran Tran; Jiamin Zheng; Richard Camicioli; Liang Li; Roger A Dixon
Journal:  Front Aging Neurosci       Date:  2018-10-02       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.